IMUNON Appoints Stacy R. Lindborg As President And CEO, Effective May 13, 2024
Assumes leadership role as Company anticipates multiple near-term clinical milestones Brings extensive leadership and experience in drug development and business strategyLAWRENCEVILLE, N.J., May 08, 2024 (GLOBE